Author from China blames translation company for plagiarism in retracted vascular paper

apjcpDo we need a “throwing vendors under the bus” category here at Retraction Watch?

Earlier this year, we reported on the retraction of a paper because of sloppy work by an outside lab. Now, we have the story of a retraction for “negligence” by a translator. Specifically, the author says the passages shared between the retracted 2015 vascular paper and another paper in EMBO Journal are a result of “negligence on the part of the translation company that I trusted to make my manuscript ready for submission.”

Here’s more from the notice in the Asian Pacific Journal of Cancer Prevention, written by Yong Jiang, of Laboratory Medical College, Jilin Medical College, China: Continue reading Author from China blames translation company for plagiarism in retracted vascular paper

Biology team with two retractions now correcting references to nixed papers

Screen Shot 2015-04-14 at 5.59.20 PMA team of biologists that retracted two papers after being “unable to replicate some of the results obtained by the first author of the paper” has now issued a correction to fix references to the two sunk publications.

The corrected paper is a review in the Journal of Virology — known there as a Gem — which discusses how viruses use the membranes of endoplasmic reticulum (ER) to replicate.

The two retractions were not signed by their first author, Riccardo Bernasconi, who won the STSBC-Roche Diagnostics award for one of the papers in 2012. The correction carries all three authors’ names, including Bernasconi’s (as second author).

Here’s more from the correction for “How Viruses Hijack the ERAD Tuning Machinery”: Continue reading Biology team with two retractions now correcting references to nixed papers

Nature retracts epigenetics paper by author who lost two Science papers last year

cover_natureFrank Sauer, formerly of the University of California, Riverside, has had a 2002 letter on epigenetics retracted from Nature due to “inappropriate image manipulation.”

Sauer had two papers retracted from Science last year following a university investigation. Here’s the Nature notice for “Histone methylation by the Drosophila epigenetic transcriptional regulator Ash1:” Continue reading Nature retracts epigenetics paper by author who lost two Science papers last year

Other shoe drops for MIT cancer researcher Robert Weinberg as Cell retraction appears

cell cloningRobert Weinberg, a prominent cancer scientist whose papers often notch hundreds or thousands of citations, has lost a fourth paper, this time a 2009 publication in Cell.

Journal Genes and Development pulled two of Weinberg’s papers in March, stating that they had retracted the 2009 study because data from several experiments was used in figures that seemed to represent only one. The Genes and Development papers were sunk because the “same analytical methodology was used.”

At the time, the Cell retraction was unavailable, though a spokesperson informed us it was forthcoming. The paper has been cited 482 times, according to Thomson Scientific’s Web of Knowledge.

Now that the notice has landed, here’s why the paper is being retracted: Continue reading Other shoe drops for MIT cancer researcher Robert Weinberg as Cell retraction appears

Cell biologists in South Korea retract two papers

jbcA group of researchers at two universities in South Korea have retracted two cell biology papers featuring retinoic acid.

The most recent retraction appears in the Journal of Biological Chemistry. Although, in typical JBC fashion, the reason for it is anyone’s guess.

Here’s the unhelpful notice for “ASXL1 represses retinoic acid receptor-mediated transcription through associating with HP1 and LSD1:” Continue reading Cell biologists in South Korea retract two papers

Second cell bio retraction from UPitt investigation of tweaked images

Journal of Cellular Physiology: Volume 229, Number 10, October 2Two researchers, Tong Wu and Chang Han, have lost a second paper as the result of a University of Pittsburgh investigation into image manipulations.

The first retraction, in Journal of Cellular Biochemistry, went live in February. The researchers, currently based at Tulane University, were originally tapped by pseudonymous tipster Juuichi Jigen, who created a website in 2012 to chronicle the allegations.

The blog lists six papers by the pair with supposedly questionable figures. According to Jigen, this latest retraction, in the Journal of Cellular Physiology, contains a figure (2A) that appears to reuse data from another paper, and another figure (3) where the data appear to be manipulated.

Continue reading Second cell bio retraction from UPitt investigation of tweaked images

Are retractions more frequent in stem cell research?

sci eng ethicsThere are a number of fields that seem to punch above their weight on Retraction Watch: Anesthesiology, home to the world record holder (and runner-up), and psychology, home to Diederik Stapel and others. But the red-hot field of stem cell research is another that makes frequent appearances, last year’s STAP controversy being particularly prominent.

There’s an interesting (but unfortunately paywalled) recent paper in Science and Engineering Ethics, “The Acid Test for Biological Science: STAP Cells, Trust, and Replication,” by Cheryl Lancaster, a small part of which tries to answer that question.

Lancaster applies the same methods Fang, Steen, and Casadevall used to broadly measure the causes of retractions in all life science and biomedicine to the specific field of stem cell research: Continue reading Are retractions more frequent in stem cell research?

Figure dupe sinks cell bio paper

cellular biohemTulane researchers Tong Wu and Chang Han, who have been anonymously accused of figure duplication in the past, have now finally lost a paper for that reason.

The frequent plagiarism tipster Juuichi Jigen (a pseudonym) set up a blog in 2012 alleging that the pair inappropriately reused images in six other papers, though none of those have been retracted. The recent notice, issued at the end of January by the Journal of Cellular Biochemistry, states that the figure duplication was confirmed by the University of Pittsburgh’s Office of Research Integrity. Han, the first author, was at UPitt when the paper was published in 2008, though she moved to join Wu at Tulane in 2009.

Here’s the notice for “Regulation of Wnt/ß-Catenin Pathway by cPLA2α and PPARδ“: Continue reading Figure dupe sinks cell bio paper

Fourth retraction appears for cancer researcher Anil Jaiswal

cancer research 1113The hits keep coming for University of Maryland researcher Anil Jaiswal.

The latest retraction for the cell biologist is in Cancer Research, for a 2007 paper about ways in which the cell tries to protect the tumor suppressor p53. Like the first Jaiswal retraction we covered, the latest notice specifically taps figure duplication as the cause of death, “as a result of an error.” The other two retractions gave no explanation for the withdrawal.

Here’s the notice: Continue reading Fourth retraction appears for cancer researcher Anil Jaiswal

Authors retract 2007 PNAS paper on aging due to figure’s “unintentional anomalies”

pnas 2515The authors of a 2007 PNAS paper that provided molecular details for how calorie restriction may act on Sir2 enzymes to extend life are now retracting their research after discovering a figure was compromised by “several unintentional anomalies in the background image.”

According to study author David W. Piston at Vanderbilt University, first author Qinghong Zhang cut and pasted images together to beautify a figure showing how a form of sugar affects the expression of SIRT1, the mammalian version of the Sir2 enzyme: Continue reading Authors retract 2007 PNAS paper on aging due to figure’s “unintentional anomalies”